Experimental
Crystal data (Tohyama & Sanemitsu, 2001) as bioactive groups. Recently, focusing on incorporating an alkyloxyacetate group into 1H-pyrazol-3-oxy derivatives in the hope of obtaining compounds with potential bioactivities, we report here the crystal structure of the title compound (I).
In the molecule of I (Fig.1 ) the bond lengths (Allen et al., 1987) 
The title compound was prepared by the literature method (Liu et al., 2011) . Crystals suitable for X-ray analysis were obtained by dissolving I (0.5 g) in ethyl acetate (25 ml) and evaporating the solvent slowly at room temperature for about 10 d.
Refinement
H atoms were positioned geometrically, with C-H = 0.93, 0.97 and 0.96 Å for aromatic, methylene and methyl H, respectively, and constrained to ride on their parent atoms, with U iso (H) = xU eq (C), where x = 1.2 for aromatic H, and x = 1.5 for other H. Figures   Fig. 1 . The molecular structure of (I), with the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. 
